Zomedica Announces Designation of PulseVet® System as the Official Shock Wave Therapy of the National Cutting Horse AssociationAccesswire • 09/06/22
Zomedica Announces Second Quarter 2022 Financial Results of $4.2 Million of Revenue; 71% Gross Margin & $186.8 Million in Cash; Revenue up 51% from 2021 Combined RevenuesAccesswire • 08/15/22
Zomedica Announces Designation of PulseVet(R) System as the Official Shock Wave Therapy Supplier of the United States Equestrian TeamAccesswire • 06/28/22
Zomedica to Acquire Assets of Innovative Veterinary Imaging Company Revo SquaredAccesswire • 06/15/22
Zomedica to Investigate Shock Wave Therapy of Exercised Induced Pulmonary Hemorrhage in HorsesAccesswire • 06/13/22
Karen DeHaan-Fullerton Joins Zomedica as General Counsel and Corporate SecretaryAccesswire • 06/02/22